Chara Papadaki
- Cancer Research top 5%
- MicroRNA in disease regulation 13
- Cancer Genomics and Diagnostics 10
- Cancer-related molecular mechanisms research 10
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 8
- Cancer Cells and Metastasis 5
-
- Circular RNAs in diseases 12
-
- Lung Cancer Treatments and Mutations 14
- Co-authors
- John SouglakosDimitriοs MavroudisVassilis GeorgouliasMaria TrypakiSofia AgelakiMaria SfakianakiDimitris MavroudisEfstathios N. Stathopoulos
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (9 papers)PLoS ONE (6 papers)
- Partner nations
- GreeceUnited StatesSweden
In The Last Decade
Chara Papadaki
51 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 77
- Cancer Research 435
- Oncology 493
- Molecular Biology 559
- Pulmonary and Respiratory Medicine 257
- Pathology and Forensic Medicine 113
Countries citing papers authored by Chara Papadaki
This map shows the geographic impact of Chara Papadaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chara Papadaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chara Papadaki more than expected).
Fields of papers citing papers by Chara Papadaki
This network shows the impact of papers produced by Chara Papadaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chara Papadaki. The network helps show where Chara Papadaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chara Papadaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2021 | 17 | |
| 4 | 2021 | 0 | |
| 5 | 2021 | 38 | |
| 6 | 2020 | 20 | |
| 7 | 2020 | 21 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 9 | |
| 11 | 2018 | 64 | |
| 12 | 2018 | 18 | |
| 13 | 2018 | 5 | |
| 14 | 2015 | 12 | |
| 15 | 2014 | 51 | |
| 16 | 2013 | 27 | |
| 17 | 2012 | 44 | |
| 18 | 2010 | 22 | |
| 19 | 2003 | 9 | |
| 20 | 1999 | 39 |
About Chara Papadaki
Chara Papadaki is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 53 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (12 papers), Cancer Genomics and Diagnostics (10 papers), Cancer-related molecular mechanisms research (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Cancer Research (435 citations), Oncology (493 citations) and Molecular Biology (559 citations). Chara Papadaki has collaborated with scholars based in Greece, United States and Sweden. Frequent co-authors include John Souglakos, Dimitriοs Mavroudis, Vassilis Georgoulias, Maria Trypaki, Sofia Agelaki, Maria Sfakianaki, Dimitris Mavroudis, Efstathios N. Stathopoulos, Anastasios Koutsopoulos and Eleni Lagoudaki. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.